Abnormalities were most commonly seen in sicker patients with the virus who were also admitted to the intensive care unit, according to recent research.
A new study of more than half a million Swedish women found that early screening reduces the risk of dying from the disease by 41% within a decade of diagnosis.
Nuclear medicine experts found that 18F-PSMA-1007 performed just as well as 68Ga-PSMA for staging individuals with intermediate- or high-risk forms of the disease.
As dental and oral-surgery offices begin to reopen in the U.S. on a state-by-state basis, oral-radiology experts in hard-hit Iran are offering tips from their experience with COVID-19.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.
